Page 53 - CIBERER2016-ENG

Most relevant scientific articles
• Bárez-López S, Obregon MJ, Martínez-de-Mena R, Bernal J, Guadaño-Ferraz A, Morte B. Effect of Triiodothyroacetic Acid Treatment in Mct8 Deficiency: A Word of Caution.Thyroid: official journal of the American Thyroid Association. 2016.
• Iwayama H., Liao X.-H., Braun L., Barez-Lopez S., Kaspar B., Weiss R.E. et al. Adeno Associated Virus 9-Based Gene Therapy Delivers a Functional Monocarboxylate Transporter 8, Improving Thyroid Hormone Availability to the Brain of Mct8-Deficient Mice. Thyroid. 2016;26(9):1311-1319.
• Patrizia Stohn J, Elena Martinez M, Matoin K, Morte B, Bernal J, Anne Galton V et al. MCT8 Deficiency in Male Mice Mitigates the Phenotypic Abnormalities Associated with the Absence of a Functional Type 3 Deiodinase.Endocrinology. 2016; en20161162.
• España-Serrano L, Guerra Martín-Palanco N, Montero-Pedrazuela A, Pérez-Santamarina E, Vidal R, García-Consuegra I et al. The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors.Cerebral cortex (New York, N.Y.: 1991). 2016.
Hightlights
Project: “Therapeutics for the Allan-Herndon-Dudley: Assessing new treatment delivery pathways” Sherman Foundation OTR02211, 2016-2017. 39.616 €. IP: Ana Guadaño Ferraz.
Invited participation in scientific meeting, organized by patient’s assocation: MCT8 Symposium 2016, Current Knowledge, Future Research on Treatment.Sherman Foundation. (Síndrome de Allan-Herndon- Dudley). Los Angeles, California, January 2016.
Organization of scientific meetings:
1. Simposium: “Hormonas tiroideas y sistema nervioso central: De lo común a lo raro”. Organizer: Beatriz
Morte Molina. 16 de junio de 2016.
2. Ana Guadaño Ferraz organizing committee for the 3rd Symposium on Biomedical Research on
“Advances and Perspectives in Neuroscience” Instituto de Investigaciones Biomédicas “Alberto Sols”
(CSIC-UAM) and Facultad de Medicina (UAM).
3. Juan Bernal is a member of the program committee for the Congreso de la Sociedad Española de
Endcrinología, Barcelona, Octiber 2017.
Diagnosis: We have performed genetic diagnosis of rare diseases of the thyroid. Specifically for the diagnosis of Familial Dysalbuminemic Hyperthyroxinemia, Resistance to thyrod hormones, Resistance to TSH, and MCT8 defects.
ER
research groups 53